Europlasma [ALEUP] vs Aurea [AURE] Detailed Stock Comparison
Europlasma
Euronext
Loading...
Aurea
Euronext
Loading...
TLDR: Quick Comparison Summary
Based on 18 vital metrics comparison: Europlasma wins in 7 metrics, Aurea wins in 8 metrics, with 0 ties. Aurea appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Europlasma | Aurea | Better |
|---|---|---|---|
| P/E Ratio (TTM) | -0.21 | 56.36 | Europlasma |
| Price-to-Book Ratio | N/A | 0.79 | N/A |
| Debt-to-Equity Ratio | -1.23 | 72.06 | Europlasma |
| PEG Ratio | N/A | 21.38 | N/A |
| EV/EBITDA | -0.82 | 5.77 | Europlasma |
| Profit Margin (TTM) | -35.71% | 0.43% | Aurea |
| Operating Margin (TTM) | -56.40% | 1.35% | Aurea |
| EBITDA Margin (TTM) | N/A | 1.35% | N/A |
| Return on Equity | 137.19% | 1.45% | Europlasma |
| Return on Assets (TTM) | -30.38% | 1.34% | Aurea |
| Free Cash Flow (TTM) | $-12.40M | $6.84M | Aurea |
| 1-Year Return | 0.00% | 21.83% | Aurea |
| Price-to-Sales Ratio (TTM) | 0.13 | 0.24 | Europlasma |
| Enterprise Value | $11.35M | $79.89M | Aurea |
| EV/Revenue Ratio | 0.27 | 0.33 | Europlasma |
| Revenue per Share (TTM) | $211 | $26 | Europlasma |
| Earnings per Share (Diluted) | $-0.02 | $0.11 | Aurea |
| Beta (Stock Volatility) | 1.51 | 0.72 | Aurea |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Europlasma vs Aurea Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Europlasma | -9.09% | 0.00% | 0.00% | 0.00% | -66.67% | -75.00% |
| Aurea | -0.65% | 0.66% | 5.86% | 10.04% | 8.87% | 13.28% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Europlasma | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Aurea | 21.83% | -27.76% | 34.65% | 15.41% | 18.99% | 18.99% |
Performance & Financial Health Analysis: Europlasma vs Aurea
| Metric | ALEUP | AURE |
|---|---|---|
| Market Information | ||
| Market Cap | €5.38M | €57.98M |
| Market Cap Category | Small cap | Small cap |
| 10 Day Avg. Volume | 36,367,142 | 1,467 |
| 90 Day Avg. Volume | 31,260,648 | 1,855 |
| Last Close | €0.00 | €6.10 |
| 52 Week Range | €0.00 - €0.25 | €4.78 - €7.30 |
| % from 52W High | -98.82% | -16.44% |
| All-Time High | €0.01 (Jun 10, 2025) | €13.40 (Mar 07, 2022) |
| % from All-Time High | N/A | -54.48% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 2.29% | -0.04% |
| Quarterly Earnings Growth | N/A | N/A |
| Financial Health | ||
| Profit Margin (TTM) | -0.36% | 0.00% |
| Operating Margin (TTM) | -0.56% | 0.01% |
| Return on Equity (TTM) | 1.37% | 0.01% |
| Debt to Equity (MRQ) | -1.23 | 72.06 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | €-0.20 | €7.89 |
| Cash per Share (MRQ) | €0.03 | €3.29 |
| Operating Cash Flow (TTM) | €-10,884,000 | €15.77M |
| Levered Free Cash Flow (TTM) | €-5,817,000 | €4.94M |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | N/A |
| Last 12-Month Dividend | N/A | N/A |
Valuation & Enterprise Metrics Analysis: Europlasma vs Aurea
| Metric | ALEUP | AURE |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | -0.21 | 56.36 |
| Forward P/E | N/A | 21.38 |
| PEG Ratio | N/A | 21.38 |
| Price to Sales (TTM) | 0.13 | 0.24 |
| Price to Book (MRQ) | N/A | 0.79 |
| Market Capitalization | ||
| Market Capitalization | €5.38M | €57.98M |
| Enterprise Value | €11.35M | €79.89M |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 0.27 | 0.33 |
| Enterprise to EBITDA | -0.82 | 5.77 |
| Risk & Other Metrics | ||
| Beta | 1.51 | 0.72 |
| Book Value per Share (MRQ) | €-0.20 | €7.89 |
Financial Statements Comparison: Europlasma vs Aurea
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | ALEUP | AURE |
|---|---|---|
| Revenue/Sales | N/A | N/A |
| Cost of Goods Sold | N/A | N/A |
| Gross Profit | N/A | N/A |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | N/A | N/A |
| EBITDA | N/A | N/A |
| Pre-Tax Income | N/A | N/A |
| Income Tax | N/A | N/A |
| Net Income (Profit) | N/A | N/A |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | ALEUP | AURE |
|---|---|---|
| Cash & Equivalents | €1.74M | €30.84M |
| Total Current Assets | €38.66M | €113.89M |
| Total Current Liabilities | €50.30M | €85.05M |
| Long-Term Debt | €10.18M | €36.18M |
| Total Shareholders Equity | €-11.15M | €73.88M |
| Retained Earnings | €-15.29M | €56.37M |
| Property, Plant & Equipment | €53.24M | €34.60M |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | ALEUP | AURE |
|---|---|---|
| Operating Cash Flow | N/A | N/A |
| Capital Expenditures | N/A | N/A |
| Free Cash Flow | N/A | N/A |
| Debt Repayment | N/A | N/A |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | ALEUP | AURE |
|---|---|---|
| Shares Short | N/A | N/A |
| Short Ratio | N/A | N/A |
| Short % of Float | N/A | N/A |
| Average Daily Volume (10 Day) | 36,367,142 | 1,467 |
| Average Daily Volume (90 Day) | 31,260,648 | 1,855 |
| Shares Outstanding | 47.79M | 9.37M |
| Float Shares | N/A | 1.51M |
| % Held by Insiders | N/A | 0.74% |
| % Held by Institutions | N/A | 0.09% |
Dividend Analysis & Yield Comparison: Europlasma vs Aurea
| Metric | ALEUP | AURE |
|---|---|---|
| Last 12-Month Dividend | N/A | N/A |
| Last 12-Month Dividend Yield | N/A | N/A |
| 3-Year Avg Annual Dividend | N/A | N/A |
| 3-Year Avg Dividend Yield | N/A | N/A |
| 3-Year Total Dividends | N/A | N/A |
| Ex-Dividend Date | N/A | N/A |